ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+20.52%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$288M
AUM Growth
+$288M
Cap. Flow
-$41.1M
Cap. Flow %
-14.26%
Top 10 Hldgs %
99.5%
Holding
15
New
–
Increased
1
Reduced
1
Closed
2

Top Buys

1
CMPS
Compass Pathways
CMPS
$669K

Top Sells

1
VRNA
Verona Pharma
VRNA
$31.7M
2
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
$10M
3
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$46.2K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$210M 72.72%
6,068,125
– –
VRNA
2
Verona Pharma
VRNA
$9.16B
$39.1M 13.54%
615,352
-500,000
-45% -$31.7M
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$12.6M 4.36%
1,025,000
– –
BCAX
4
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$7.41M 2.57%
568,919
– –
GLUE icon
5
Monte Rosa Therapeutics
GLUE
$296M
$6.83M 2.37%
1,472,331
– –
NUVB icon
6
Nuvation Bio
NUVB
$1.02B
$4.47M 1.55%
2,541,009
– –
CMPS
7
Compass Pathways
CMPS
$424M
$3.43M 1.19%
1,198,418
+233,918
+24% +$669K
BMEA icon
8
Biomea Fusion
BMEA
$116M
$1.7M 0.59%
798,757
– –
CALC icon
9
CalciMedica
CALC
$37.7M
$995K 0.35%
521,114
– –
ELEV
10
DELISTED
Elevation Oncology
ELEV
$735K 0.25%
2,834,910
– –
ACRS icon
11
Aclaris Therapeutics
ACRS
$209M
$665K 0.23%
434,455
– –
MRKR icon
12
Marker Therapeutics
MRKR
$12M
$400K 0.14%
325,370
– –
OKUR
13
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$381K 0.13%
88,607
– –
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-288,571
Closed -$46.2K
PSTX
15
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-1,043,267
Closed -$10M